Heights Capital Management »

Conduit Pharmaceuticals shares owned by Heights Capital Management

Quarter-by-quarter ownership of Conduit Pharmaceuticals (CDTTW) shares owned by Heights Capital Management from 13F filings

Historical chart of Heights Capital Management investment in Conduit Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Conduit Pharmaceuticals held by Heights Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Conduit Pharmaceuticals by Heights Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $931 79k 0.01

More positions owned by Heights Capital Management

Flutter Entmt SHS (FLUT)
Oatly Group Ab Note 9.250% 9/1 (Principal)
Sable Offshore Corp Com Shs (SOC)
Gp-act Iii Acquisition Corp Cl A
Future Vision Ii Acquisition Unit 06/20/2029
Flag Ship Acquisition Corp Ord Shs
Cantor Equity Partners Shs Cl A
Ib Acquisition Corp Com Shs (IBAC)
Voyager Acquisition Corp Unit 99/99/9999
Haymaker Acquisition Corp Iv Class A (HYAC)
Iron Horse Acquisitions Corp (IROH)
Cayson Acquisition Corp Unit 99/99/9999
Nyxoah S A SHS (NYXH)
Blacksky Technology Cl A New
Goldenstone Acq Crp; Tnt Acq Dt: 12/21/2023; Cash: $10.15 (GDST)

View all positions for Heights Capital Management

Top funds holding Conduit Pharmaceuticals

Highbridge Capital Management
Polar Securities
Saba Capital Management
MMCAP International Inc. SPC
Exos Asset Management
Clear Street
D. E. Shaw & Co
Wolverine Asset Management
Atw Spac Management
Arena Investors
Mizuho Securities USA
CNH Partners
Periscope Capital
Cowen And Company
Rivernorth Capital Management

View all funds holding Conduit Pharmaceuticals